精子线粒体DNA标志物与夫妇生育力
这项基于美国16个县2005-2009年招募的384对停止避孕夫妇的前瞻性队列研究发现,精子线粒体DNA拷贝数(mtDNAcn)较高者,周期特异性妊娠几率降低多达50%,12个月内妊娠概率降低18%。精子mtDNA缺失(mtDNAdel)与妊娠时间无关。提示精子mtDNAcn可作为普通人群男性生育健康及妊娠成功概率的生物标志物。
要点
- 精子mtDNAcn最高四分位组12个月妊娠概率为63.5%,最低四分位组为82.3%(P=0.002)。
- 校正协变量后,mtDNAcn第二、三、四分位组生育力 odds 比分别为0.78、0.65、0.55。
- 精子mtDNAdel与妊娠时间无显著关联。
核心结论
- 精子mtDNAcn较高与夫妇妊娠概率降低和妊娠时间延长相关,可作为普通人群男性生育力的生物标志物。
- 精子mtDNAdel与妊娠时间无关。
研究设计与样本
- 基于美国16个县2005-2009年招募的停止避孕拟妊娠夫妇的前瞻性队列研究,随访至16个月。
- 共评估384份精液样本的mtDNAcn和mtDNAdel,采用三重探针定量PCR检测。
主要发现
- 未校正四分位比较:mtDNAcn Q4组12个月内妊娠概率为63.5%(95%CI 53.1%-73.1%),Q1组为82.3%(95%CI 73.2%-89.9%),P=0.002。
- 校正协变量后,相对Q1组,Q2组生育力 odds 比(FOR)为0.78(95%CI 0.52-1.16),Q3组为0.65(95%CI 0.44-0.96),Q4组为0.55(95%CI 0.37-0.81)。
- 随mtDNAcn四分位升高,生育力下降趋势显著(每log mtDNAcn的FOR=0.37,P<0.001)。
- 精子mtDNAdel与妊娠时间无显著关联。
关键数值与推荐
- 精子mtDNAcn Q4组12个月内妊娠概率63.5%(95%CI 53.1%-73.1%),Q1组82.3%(95%CI 73.2%-89.9%),P=0.002。
- 校正后FOR:Q2=0.78(95%CI 0.52-1.16),Q3=0.65(95%CI 0.44-0.96),Q4=0.55(95%CI 0.37-0.81)。
- 每log mtDNAcn的FOR=0.37,P<0.001。
临床怎么用
- 精子mtDNAcn可作为评估男性生育健康及自然妊娠成功概率的潜在生物标志物。
- 对于精液常规参数无法充分预测生育结局的夫妇,可考虑检测精子mtDNAcn以辅助咨询。
局限性
- 研究人群以白种人为主,需在多样化种族/族裔队列中验证。
- 研究为观察性设计,不能确定因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Do sperm mitochondrial DNA measures predict probability of pregnancy among couples in the general population? SUMMARY ANSWER: Those with high sperm mitochondrial DNA copy number (mtDNAcn) had as much as 50% lower odds of cycle-specific pregnancy, and 18% lower probability of pregnancy within 12 months. WHAT IS KNOWN ALREADY: Semen parameters have been found to poorly predict reproductive success yet are the most prevalent diagnostic tool for male infertility. Increased sperm mtDNAcn and mitochondrial DNA deletions (mtDNAdel) have been associated with decreased semen quality and lower odds of fertilization in men seeking fertility treatment. STUDY DESIGN, SIZE, DURATION: A population-based prospective cohort study of couples discontinuing contraception to become pregnant recruited from 16 US counties from 2005 to 2009 followed for up to 16 months. PARTICIPANTS/MATERIALS, SETTING, METHODS: Sperm mtDNAcn and mtDNAdel from 384 semen samples were assessed via triplex probe-based quantitative PCR. Probability of pregnancy within 1 year was compared by mitochondrial DNA, and discrete-time proportional hazards models were used to evaluate the relations with time-to-pregnancy (TTP) with adjustment for covariates. MAIN RESULTS AND THE ROLE OF CHANCE: Higher sperm mtDNAcn was associated with lower pregnancy probability within 12 months and longer TTP. In unadjusted comparisons by quartile (Q), those in Q4 had a pregnancy probability of 63.5% (95% CI: 53.1% to 73.1%) compared to 82.3% (95% CI: 73.2% to 89.9%) for Q1 (P = 0.002). Similar results were observed in survival analyses adjusting for covariates to estimate fecundability odds ratios (FORs) comparing mtDNAcn in quartiles. Relative to those in Q1 of mtDNAcn, FORs (95% CI) were for Q2 of 0.78 (0.52 to 1.16), Q3 of 0.65 (0.44 to 0.96) and Q4 of 0.55 (0.37 to 0.81), and this trend of decreasing fecundability with increasing mtDNAcn quartile was statistically significant (FOR per log mtDNAcn = 0.37; P < 0.001). Sperm mtDNAdel was not associated with TTP. LIMITATIONS, REASONS FOR CAUTION: This prospective cohort study consisted primarily of Caucasian men and women and thus large diverse cohorts are necessary to confirm the associations between sperm mtDNAcn and couple pregnancy success in other races/ethnicities. WIDER IMPLICATIONS OF THE FINDINGS: Our results demonstrate that sperm mtDNAcn has utility as a biomarker of male reproductive health and probability of pregnancy success in the general population. STUDY FUNDING/COMPETING INTEREST(S): This work was funded in part by the National Institute of Environmental Health Sciences, National Institutes of Health (R01-ES028298; PI: J.R.P.) and the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland (Contracts N01-HD-3-3355, N01-HD-3-3356 and N01-HD-3-3358). The authors declare no competing interests. TRIAL REGISTRATION NUMBER: N/A.
引用
- Rosati AJ, Whitcomb BW, Brandon N, et al. Sperm mitochondrial DNA biomarkers and couple fecundity. Hum Reprod. 2020. PMID: 33021643. doi:10.1093/humrep/deaa191
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。